GlaxoSmithKline plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) and Sanofi are Dominating in the Global Vaccine Market in 2020

Global Vaccines Market is expected to grow with the CAGR of 6.9% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-vaccines-market

Global vaccines market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global vaccines market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement into the vaccines market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in November 2020, GlaxoSmithKline plc along with Medicines for Malaria Venture presented a positive data (TEACH study) of tafenoquine used for the treatment of Plasmodium vivax malaria in children and adolescents. During the four months of examination, 95% of studied 60 subjects that did not show the signs of Plasmodium vivax malaria. The results were presented through virtual annual meeting of American Society of Tropical Medicine & hygiene 2020. This has helped the company to move forward on the product for the treatment of malaria and to provide the evidence of their product.

GlaxoSmithKline plc is the dominating player in global vaccines market. The other key players existing in the vaccines market includes Bharat Biotech, Biological E Limited, Bio Farma, Emergent BioSolutions Inc., Dynavax Technologies, Valneva SE, Bavarian Nordic, Altimmune, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.), Takeda Pharmaceutical Company Limited, Seqirus (a subsidiary of CSL Limited), Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, ALK, Panacea Biotec Ltd, BAXTER VACCINES (a subsidiary of Baxter), Lanzhou Biological Products Research Institute Co., Ltd., Serum Institute of India Pvt. Ltd. among others.

Vaccine MarketGlaxoSmithKline plc:

GlaxoSmithKline plc is headquartered in Brentford, U.K. and was founded in 1715. The company is focused to become one of the best companies in the field of innovation, development of drugs and vaccines that will be beneficial to both patient and consumers. The company deals in multiple business segments such as pharmaceuticals, vaccines and consumer healthcare among which vaccines is the market focused segment. The company provides various products under categories such as prescription medicines, vaccines, consumer healthcare products, ViiV healthcare and stiefel dermatology among which vaccines is the market focused category.

For instance,

  • In April 2020, GlaxoSmithKline plc announced the collaboration with Sanofi for developing the COVID-19 vaccine using their technologies. Sanofi will provide S-protein COVID-19 antigen based on recombinant DNA technology whereas GlaxoSmithKline plc will contribute with their adjuvant technology. This technology will reduce the number of doses given to the patients. The companies planned to start the clinical trials (phase I) in 2020 and if the results are successful, then it will be launched in 2021. This collaboration has helped the company to increase the development of the candidate vaccine.

The company has presence across Asia, Middle East and Africa, Australasia, Europe and Americas. The company generates revenue through various subsidiary companies such as GlaxoSmithKline Pharmaceuticals Ltd (Mumbai), Tesaro (U.S.), GlaxoSmithKline Pakistan (Pakistan), Stiefel Laboratories (U.S.), Allen & Hanburys (U.K.) among others.

Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.):

Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) is headquartered in New Jersey, U.S. and was founded in 1953. The company is focused on inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in order to save and improve lives. The company provides various products under categories such as oncology, vaccines, infectious diseases, COVID-19 and cardio-metabolic disorders among which vaccines is the market focused category.

For instance,

  • In May 2020, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) collaborated with IAVI for development of novel vaccine against the SARS-CoV-2. The vaccine under development use the recombinant vesicular stomatitis virus technology which is the first technology approved for Ebola Zaire virus vaccine indicated for human use. This collaboration leverage the company’s research and developmental activities.

The company has wide presence across Americas, Europe, Middle East and Africa and Asia-Pacific. The company generates revenue through various subsidiary companies such as Merck Sharp & Dohme (Australia) Pty. Ltd (Australia), Merck Sharp & Dohme (Malaysia) Sdn. Bhd. (Malaysia), MSD Finland Oy (Finland), Merck Sharp & Dohme B.V. (Netherlands), Merck Sharp & Dohme (Sweden) A.B. (Sweden) among others.

Sanofi:

Sanofi is headquartered in Paris, France. The company is focused on protecting, enabling and supporting people facing health challenges so that they can live life with their whole potential. The company deals in multiple business segments such as pharmaceuticals, vaccines and consumer healthcare among which vaccines is the market focused segment. The company provides various products under categories such as health and well-being, diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, rare blood disorders and vaccines among which vaccines is the market focused category.

For instance,

  • In November 2020, Sanofi has received approval from European commission for Supemtek (quadrivalent recombinant influenza vaccine) for prevention of influenza disease in adults aged 18 years or older than that. This approval helped the company to advance its product portfolio involving vaccines and to strengthen its root in European vaccines market.

The company has wide presence across America, Europe, Middle East and Africa and Asia-Pacific. The company generates revenue through various subsidiary companies such as Sanofi Medley Farmacêutica Ltda. (Brazil), Genzyme Europe B.V. (Netherlands), Bioverativ USA Inc. (U.S.), Sanofi-Aventis U.S. LLC (U.S.), sanofi-aventis Canada Inc. (Canada) among others.


Browse Related Reports

Global Conjugate Vaccines Market – Industry Trends and Forecast to 2028

Global Flu Vaccines Market – Industry Trends and Forecast to 2027

Global Veterinary-Animal Vaccines Market – Industry Trends and Forecast to 2028

Global Deoxyribonucleic Acid (DNA) Vaccines Market – Industry Trends and Forecast to 2028

Global Bovine Ephemeral Fever Vaccines Market – Industry Trends and Forecast to 2028

Global Companion Animal Vaccines Market - Industry Trends and Forecast to 2026

Global Personalized Cancer Vaccines Market - Industry Trends and Forecast to 2028

Global Avian Influenza Vaccines Market – Industry Trends and Forecast to 2027

Global Cholera Vaccines Market - Industry Trends and Forecast to 2027

Global Meningococcal Vaccines Market - Industry Trends and Forecast to 2027

Global Human Rabies Vaccines Market - Industry Trends and Forecast to 2027

Global Poultry Vaccines Market - Industry Trends and Forecast to 2028

Global Human Combination Vaccines Market - Trends and Forecast to 2028

Asia-Pacific Vaccines Market – Industry Trends and Forecast to 2028

Europe Vaccines Market – Industry Trends and Forecast to 2028

North America Vaccines Market – Industry Trends and Forecast to 2028

Middle East and Africa Vaccines Market – Industry Trends and Forecast to 2028

Global Measles, Mumps and Rubella Vaccines Market – Industry Trends and Forecast to 2028

Global Toxoid Vaccines Market – Industry Trends and Forecast to 2028

Global Live Attenuated Vaccines Market - Industry Trends and Forecast to 2026

Global Porcine Vaccines Market - Industry Trends and Forecast to 2027

Global Inactivated Vaccines Market – Industry Trends and Forecast to 2027

Global Vaccines Market – Industry Trends and Forecast to 2028

Global Malaria Vaccines Market - Industry Trends and Forecast to 2027

Global Bacterial Vaccines Market - Industry Trends and Forecast to 2027

Global Preventable Vaccines Market - Industry Trends and Forecast to 2027